Placebo for BMS-936558, OPDIVO 10 mg/mL concentrate for solution for infusion.
CA209-577
Phase 3 small_molecule active
Quick answer
Placebo for BMS-936558, OPDIVO 10 mg/mL concentrate for solution for infusion. for Subjects with resected adenocarcinoma or squamous cell carcinoma esophageal or gastroesophageal junction cancer is a Phase 3 program (small_molecule) at Bristol-Myers Squibb / Pfizer EEIG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bristol-Myers Squibb / Pfizer EEIG
- Indication
- Subjects with resected adenocarcinoma or squamous cell carcinoma esophageal or gastroesophageal junction cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active